David Singh, MBBChir, MA (Cantab), MRCP, MD, FBPhS, FERS

David Singh, MBBChir, MA (Cantab), MRCP, MD, FBPhS, FERS, is a professor of Clinical Pharmacology & Respiratory Medicine at the University of Manchester and is the medical director of the Medicines Evaluation Unit (MEU).

Articles by David Singh, MBBChir, MA (Cantab), MRCP, MD, FBPhS, FERS

Q&A: Discussing 2027 GOLD Report Updates in COPD, With David Singh, MD

ByDavid Singh, MBBChir, MA (Cantab), MRCP, MD, FBPhS, FERS

November 6th 2026

Dave Singh, MD, reflects on 2027 GOLD report refinements, from mucus plugs and early COPD to biologics awaiting regulatory approval.

David Singh, MBBChir, MA (Cantab), MRCP, MD, FBPhS, FERS

Articles by David Singh, MBBChir, MA (Cantab), MRCP, MD, FBPhS, FERS

Q&A: Discussing 2027 GOLD Report Updates in COPD, With David Singh, MD

Latest Updated Articles

Trending on HCPLive

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Real-World Resmetirom Data Show Liver Stiffness Gains in MASH

Noninvasive Models Underestimate CSPH in MASH Cirrhosis vs HVPG

IDEAL: Seladelpar Achieves ALP Normalization in Second-Line PBC

Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study